Article
Downregulation of ACAN is Associated with the Growth hormone pathway and Induces short stature.
Journal of clinical laboratory analysis - 1 Jan 2023
Wu Huiping, Wang Chaoban, Yu Shiwen, Ye Xiaojun, Jiang Yalan, He Pingping, Shan Xiaoou
Abstract excerpt
BACKGROUND: ACAN heterozygous mutations can cause short stature in patients with or without advanced bone age and have recently attracted researchers' attention. Growth hormone can be used to treat short stature induced by ACAN mutations; however, few studies have focused on the underlying mechanism of this treatment. METHODS: Four patients with new mutations were reported based on clinical data and genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
